2025 Clinician Corner - Solitary erythematous round nodule with a hemorrhagic crust on the posterior shoulder

Overview

Abstract 

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder (PCMS-TCL) is a rare skin condition. We present a 67-year-old patient with a growing lesion on the shoulder that was diagnosed as PCMS-TCL. The patient was otherwise healthy without systemic involvement. The lesion was surgically excised, and no recurrence occurred. PCMS-TCL has an excellent prognosis, unlike other cutaneous lymphomas. This case highlights the importance of crafting a comprehensive differential diagnosis that incorporates any possibilities of rare disorders like PCMS-TCL to avoid unnecessary treatment.  

Keywords:  B-cell lymphoma; lymphoma; pseudolymphoma; T-cell lymphoma

Please click here to read the article
Please click here to subscribe to BUMC Proceedings

Faculty credentials/disclosure 

The planners and faculty for this activity have no relevant financial relationships to disclose. The patient consented to the publication of this report.

Process

Click the "add to cart/begin" button, pay any relevant fee, take the quiz, complete the evaluation, and claim your CME credit.  You must achieve 100% on the quiz with unlimited attempts available.

  • By completing this process, you are attesting that you have read the journal article.

Expiration date:

Credit eligibility for this article is set to expire on May 1, 2026.

Learning Objectives

After completing the article, the learner should be able to:

  • Identify the key distinguishing features of PCMS-TCL, including its morphology, specific immunohistochemical profile, and clinical course, to differentiate it from other cutaneous lymphomas and pseudolymphomas. 
  • Recognize PCMS-TCL as a provisional entity with uncertain malignant potential according to the WHO classification, to prevent misdiagnosis as a more aggressive lymphoma. 
  • Apply appropriate conservative management strategies for PCMS-TCL patients, understanding that aggressive treatments like chemotherapy should be avoided given the excellent prognosis and high complete remission rates with conservative therapy. 

Key Points 

  • It is crucial to differentiate pleomorphic T-cell lymphoproliferative disorder (PCMS-TCL) from other cutaneous lymphomas and pseudolymphomas. The confined nature of the lesion, specific immunohistochemical profile, and benign clinical course are key distinguishing features. 
  • PCMS-TCL has an excellent prognosis, with most patients achieving complete remission after conservative treatment. Aggressive treatments like chemotherapy are typically unnecessary and should be avoided.  
  • PCMS-TCL is classified as a provisional entity with uncertain malignant potential in the World Health Organization classification of lymphoid neoplasms. Recognizing this entity is crucial to prevent overdiagnosis as a more aggressive lymphoma. 

You may also be interested in

2025 Clinician Corner - Histologic changes of basal cell carcinomas during vismodegib treatment
We report a case of a 63-year-old man with a history of numerous basal cell carcinomas (BCCs) on vismodegib who developed a pink subcutaneous nodule that was thought to be either a BCC or an epidermal inclusion cyst. Sections displayed a dome-shaped lesion composed of large dermal nodules of epithelioid cells with variable cytology. Some of the dermal nodules demonstrated squamatization of the epithelioid cells while others had a predominantly basaloid phenotype. Central necrosis was present in the majority of the large dermal nodules, but the lesion did not stain with CK7 or CK20, helping to rule out internal metastases. The epithelial nodules stained strongly with pancytokeratin (AE1/AE3), p40, and stained lightly with BCL-2, supporting the diagnosis of BCC. However, Ber-EP4 being negative and the presence of significant squamatization suggest vismodegib can alter both the histological and immunophenotype of BCCs. This phenomenon has rarely been reported in literature. 
2025 Clinician Corner - Urrets-Zavalia syndrome and secondary acute angle-closure glaucoma induced by implantable collamer lens
Implantable collamer lenses (ICL) have revolutionized the management of high refractive errors, yet they present unique challenges. We present a case of a fixed and dilated atonic pupil following acute-angle closure glaucoma from pupillary block after ICL implantation, known as Urrets-Zavalia syndrome. A 39-year-old woman developed acute ocular pain and headaches after surgery, leading to elevated intraocular pressure and subsequent complications necessitating ICL removal. This case highlights the need for prompt identification and management of elevated intraocular pressure to prevent irreversible complications such as Urrets-Zavalia syndrome following ICL implantation.
2025 Clinician Corner - Amaurosis fugax in Takayasu arteritis mimicking migraine with visual aura
Takayasu arteritis is a rare vasculitis commonly seen in young women. Amaurosis fugax and headache are visual presentations of Takayasu arteritis. Migraine with visual aura is a common condition affecting young women, and differentiating migraine from Takayasu presenting with visual symptoms and headache can be challenging. We present a case of a young woman initially misdiagnosed with migraine with aura, who was later found to have Amaurosis fugax as an early manifestation of Takayasu arteritis.
Course summary
Available credit: 
  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 1.00 American Board of Surgery (ABS) Accredited CME
    Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • 1.00 AMA PRA Category 1 Credit™
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
05/01/2025
Course expires: 
05/01/2026
Cost:
$25.00
Rating: 
0

Faculty

  • Promise Ufomadu, BSA - School of Medicine, Baylor College of Medicine, Houston, Texas, USA 
  • Soo Jung Kim, MD - School of Medicine, Baylor College of Medicine, Houston, Texas, USA and Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA 
  • Hafeez Diwan, MD - School of Medicine, Baylor College of Medicine, Houston, Texas, USA and Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA 

Accreditation

Accreditation

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

AMA PRA Category 1 Credit™

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

ABIM MOC

 Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Available Credit

  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 1.00 American Board of Surgery (ABS) Accredited CME
    Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • 1.00 AMA PRA Category 1 Credit™
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Register/Begin

Price

Cost:
$25.00
Please login or register for this course.